All Resources

AAO23: Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines

AAO23: Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines

Download PDF

High Priority: No; N/A
Percentage of patients age 2 years and older with allergic rhinitis who are offered intranasal corticosteroids (INS) or nonsedating oral antihistamines.

Denominator:
All patients age 2 years and older with a diagnosis of allergic rhinitis.

Denominator Exclusions:
None

Denominator Exceptions:
Patients with an allergy to oral antihistamines or intranasal corticosteroids.
Patients with prostate cancer or benign prostatic hypertrophy as these patients may be intolerant of medications.
Patients with a history of epistaxis due to intranasal steroids use.
Patient refusal.

Numerator:
Patients who are taking intranasal steroids (INS) or non-sedating oral antihistamines. A prescription for or medication
reconciliation of over the counter medications can be used to identify patients taking medications.
Measure Classifications:

  • Measure Type: Process
  • National Quality Strategy (NQS) domain: Effective Clinical Care
  • Meaningful Measure Area: Medication Management
  • Calculation: 1st Performance Rate
    • Inverse measure: No
    • Continuous measure: No
    • Proportional measure: Yes
    • Ratio measure: No
    • Risk Adjusted measure: No
AAO-HNS COVID-19 InformationLearn More